Cosmi B - Search Results

1

A randomized double-blind study of low-molecular-weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum).

Cosmi B, Filippini M, Tonti D, Avruscio G, Ghirarduzzi A, Bucherini E, Camporese G, Imberti D, Palareti G; STEFLUX Investigators. Cosmi B, et al. J Thromb Haemost. 2012 Jun;10(6):1026-35. doi: 10.1111/j.1538-7836.2012.04727.x. J Thromb Haemost. 2012. PMID: 22487001 Free article. Clinical Trial.

2

A randomised, double-blind, placebo-controlled trial of dermatan sulphate for prevention of deep vein thrombosis in hip fracture.

Agnelli G, Cosmi B, Di Filippo P, Ranucci V, Veschi F, Longetti M, Renga C, Barzi F, Gianese F, Lupattelli L, et al. Agnelli G, et al. Among authors: cosmi b. Thromb Haemost. 1992 Feb 3;67(2):203-8. Thromb Haemost. 1992. PMID: 1621239 Clinical Trial.

3

Effects of standard heparin and a low molecular weight heparin (Kabi 2165) on fibrinolysis.

Agnelli G, Borm J, Cosmi B, Levi M, ten Cate JW. Agnelli G, et al. Among authors: cosmi b. Thromb Haemost. 1988 Oct 31;60(2):311-3. Thromb Haemost. 1988. PMID: 2851195 Clinical Trial.

4

The additive effect of low molecular weight heparins on thrombin inhibition by dermatan sulfate.

Cosmi B, Agnelli G, Young E, Hirsh J, Weitz J. Cosmi B, et al. Thromb Haemost. 1993 Sep 1;70(3):443-7. Thromb Haemost. 1993. PMID: 8259546

5

Low molecular weight heparins (LMWH) in the treatment of patients with acute venous thromboembolism.

Hirsh J, Siragusa S, Cosmi B, Ginsberg JS. Hirsh J, et al. Among authors: cosmi b. Thromb Haemost. 1995 Jul;74(1):360-3. Thromb Haemost. 1995. PMID: 8578485

6

[High negative predictive value for recurrence of venous thromboembolism with d-dimer carried out three months after the suspension of treatment with oral anticoagulants in patients over 60].

Palareti G, Guazzaloca G, Legnani C, Fortunato G, Grauso F, De Rosa V, Rodorigo G, Cosmi B, Coccheri S. Palareti G, et al. Among authors: cosmi b. Minerva Cardioangiol. 1998 Oct;46(10):374-5. Minerva Cardioangiol. 1998. PMID: 10021815 Clinical Trial. Italian. No abstract available.

7

Oral anticoagulant therapy: efficacy, safety and the low-dose controversy.

Coccheri S, Palareti G, Cosmi B. Coccheri S, et al. Among authors: cosmi b. Haemostasis. 1999;29(2-3):150-65. doi: 10.1159/000022495. Haemostasis. 1999. PMID: 10629394 Review.

8

[Levels of total plasma homocysteine after methionine intake in a group of healthy subjects in Northern + Italy. Relationship with age, gender, and nutritional status].

Sassi S, Cosmi B, Palareti G, Legnani C, Grossi G, Coccheri S. Sassi S, et al. Among authors: cosmi b. Minerva Cardioangiol. 1999 Dec;47(12):511-3. Minerva Cardioangiol. 1999. PMID: 10670178 Italian. No abstract available.

9

[Home use of an ambulatory monitor for the determination of prothrombin time (coaguchek) in patients treated with oral anticoagulants. Multicenter prospective study].

Cosmi B, Palareti G, Moia M, Pengo V, Testa S. Cosmi B, et al. Minerva Cardioangiol. 1999 Dec;47(12):598-9. Minerva Cardioangiol. 1999. PMID: 10670221 Clinical Trial. Italian. No abstract available.

10

Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK).

Cosmi B, Palareti G, Carpanedo M, Pengo V, Biasiolo A, Rampazzo P, Morstabilini G, Testa S. Cosmi B, et al. Haematologica. 2000 Aug;85(8):826-31. Haematologica. 2000. PMID: 10942929

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

182 results

Search Page